TARKOWSKI, MACIEJ STANISLAW
TARKOWSKI, MACIEJ STANISLAW
Dipartimento di Scienze Biomediche e Cliniche
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease
2024 M. Colaneri, G. Scaglione, F. Fassio, L. Galli, A. Lai, A. Bergna, A. Gabrieli, M. Tarkowski, C.D. Ventura, V. Colombo, L. Cordier, D. Bernasconi, M. Corbellino, G. Dedivitiis, S. Borghetti, D. Visigalli, S. Sollima, G. Casalini, G. Rizzardini, A. Gori, S. Antinori, A. Riva, M. Schiavini
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
2024 D. Dalu, M. Tarkowski, L. Ruggieri, M.S. Cona, A. Gabrieli, D. De Francesco, C. Fasola, S. Ferrario, A. Gambaro, E. Masedu, G. Parma, E. Rulli, C. De Stradis, D. Mavilio, F. Calcaterra, F. Manoni, A. Riva, N. La Verde
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
2023 M.S. Cona, A. Riva, D. Dalu, A. Gabrieli, C. Fasola, G. Lipari, G. Pozza, E. Rulli, F. Galli, L. Ruggieri, E. Masedu, G. Parma, D. Chizzoniti, A. Gambaro, S. Ferrario, M. Antista, M. De Monte, M.S. Tarkowski, N. La Verde
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
2023 N. La Verde, A. Riva, M.S. Cona, A. Gabrieli, M. Cattaneo, C. Fasola, G. Lipari, C. De Stradis, V. Favorito, B. Lombardi Stocchetti, D. Chizzoniti, A. Covizzi, E. Rulli, F. Galli, L. Ruggieri, A. Gambaro, S. Ferrario, D. Dalu, M.S. Tarkowski
Definition of the Immune Parameters Related to COVID-19 Severity
2022 S. Birindelli, M.S. Tarkowski, M. Gallucci, M. Schiuma, A. Covizzi, P. Lewkowicz, E. Aloisio, F.S. Falvella, A. Dolci, A. Riva, M. Galli, M. Panteghini
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
2021 M. Tarkowski, W. de Jager, M. Schiuma, A. Covizzi, A. Lai, A. Gabrieli, M. Corbellino, A. Bergna, C.D. Ventura, M. Galli, A. Riva, S. Antinori
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan
2021 L. Valenti, A. Bergna, S. Pelusi, F. Facciotti, A. Lai, M. Tarkowski, A. Lombardi, A. Berzuini, F. Caprioli, L. Santoro, G. Baselli, C.D. Ventura, E. Erba, S. Bosari, M. Galli, G. Zehender, D. Prati
Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease
2021 C. Defendenti, M.S. Tarkowski, S. Borille, A. Cassinotti, A. Massari, S. Birindelli, A. Riva, S. Ardizzone, M. Panteghini
H3K4me3 Histone ChIP-Seq Analysis Reveals Molecular Mechanisms Responsible for Neutrophil Dysfunction in HIV-Infected Individuals
2021 P. Piatek, M. Tarkowski, M. Namiecinska, A. Riva, M. Wieczorek, S. Michlewska, J. Dulska, M. Domowicz, M. Kulinska-Michalska, N. Lewkowicz, P. Lewkowicz
Genomic characterisation and phylogenetic analysis of SARS-COV-2 in Italy
2020 G. Zehender, A. Lai, A. Bergna, L. Meroni, A. Riva, C. Balotta, M. Tarkowski, A. Gabrieli, D. Bernacchia, S. Rusconi, G. Rizzardini, S. Antinori, M. Galli
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
2020 L. Piccoli, Y.-. Park, M.A. Tortorici, N. Czudnochowski, A.C. Walls, M. Beltramello, C. Silacci-Fregni, D. Pinto, L.E. Rosen, J.E. Bowen, O.J. Acton, S. Jaconi, B. Guarino, A. Minola, F. Zatta, N. Sprugasci, J. Bassi, A. Peter, A. De Marco, J.C. Nix, F. Mele, S. Jovic, B.F. Rodriguez, S.V. Gupta, F. Jin, G. Piumatti, G. Lo Presti, A.F. Pellanda, M. Biggiogero, M. Tarkowski, M.S. Pizzuto, E. Cameroni, C. Havenar-Daughton, M. Smithey, D. Hong, V. Lepori, E. Albanese, A. Ceschi, E. Bernasconi, L. Elzi, P. Ferrari, C. Garzoni, A. Riva, G. Snell, F. Sallusto, K. Fink, H.W. Virgin, A. Lanzavecchia, D. Corti, D. Veesler
Structural basis for broad HIV-1 neutralization by the MPER-specific human broadly neutralizing antibody LN01
2019 D. Pinto, C. Fenwick, C. Caillat, C. Silacci, S. Guseva, F. Dehez, C. Chipot, S. Barbieri, A. Minola, D. Jarrossay, G.D. Tomaras, X. Shen, A. Riva, M. Tarkowski, O. Schwartz, T. Bruel, J. Dufloo, M.S. Seaman, D.C. Montefiori, A. Lanzavecchia, D. Corti, G. Pantaleo, W. Weissenhorn
ANALYSIS OF THE FREQUENCIES OF CD235A+CD71+ PRE-ERYTHROID CELLS IN PERIPHERAL BLOOD AND THEIR FUNCTION IN HIV INFECTED PEOPLE
2017 M.S. Tarkowski
Leukocyte culture: considerations for In vitro culture of T cells in immunotoxicological studies
2016 M. Tarkowski
Peripheral blood pre-erythroidal cells in HIV-1 infection
2015 M.S. Tarkowski, L. Ghita, E. Calvi, L. Milazzo, C. Gervasoni, C. Resnati, M. Mena, P. Castelli, M.P. Allegri, C. Atzori, I. Cetin, M. Galli, A. Riva
Analyses of Pre-erythroid cells in peripheral blood of patients with different progression of HIV infection
2015 M.S. Tarkowski, L. Ghita, L. Milazzo, E. Calvi, A.M. Peri, C. Resnati, C. Gervasoni, M. Galli, A. Riva
Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients
2013 S. Likanonsakul, T. Rattanatham, S. Feangvad, S. Uttayamakul, W. Prasithsirikul, S. Srisopha, R. Nitiyanontakij, P. Tengtrakulcharoen, M. Tarkowski, A. Riva, E.E. Nakayama, T. Shioda
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers
2012 L. Ferraris, O. Viganò, A.M. Peri, M. Tarkowski, G. Milani, S. Bonora, F. Adorni, C. Gervasoni, E.G.I. Clementi, G. Di Perri, M. Galli, A. Riva
Expression of Interleukin-15 and Interleukin-15Rα in Monocytes of HIV Type 1-Infected Patients with Different Courses of Disease Progression
2012 M. Tarkowski, L. Ferraris, S. Martone, F. Strambiodecastillia, D. Misciagna, R.I. Mazzucchelli, E. Lattuada, G. Paraninfo, M. Galli, A. Riva, The ELVIS Study Group
Peripheral blood T regulatory cells and TH17 cells and their genes expression profile in HIV-1 infected patients and healthy controls
2011 M. Tarkowski, P. Lewkowicz, E. Jablonowska, D. Misciagna, A. Riva, M. Galli